Country: United States
Language: English
Source: NLM (National Library of Medicine)
TADALAFIL (UNII: 742SXX0ICT) (TADALAFIL - UNII:742SXX0ICT)
NuCare Pharmaceuticals,Inc.
ORAL
PRESCRIPTION DRUG
Tadalafil tablet is indicated for the treatment of erectile dysfunction (ED). Tadalafil tablet is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Tadalafil tablet is indicated for the treatment of ED and the signs and symptoms of BPH (ED/BPH). If tadalafil tablet is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see Clinical Studies ( 14.3)]. Administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. In clinical pharmacology studies, tadalafil tablets was shown to potentiate the hypotensive effect of nitrates [see Clinical Pharmacology ( 12.2)]. Tadalafil tablet is contraindicated in patients with a kn
Tadalafil tablets USP, 5 mg are white color, round shaped, biconvex, film-coated tablets debossed with T17 on one side and H on the other side. NDC 68071-5116-6 BOTTLES OF 60 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight container. Keep out of reach of children.
Abbreviated New Drug Application
TADALAFIL- TADALAFIL TABLET, FILM COATED NUCARE PHARMACEUTICALS,INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE TADALAFIL TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR TADALAFIL TABLETS. TADALAFIL TABLETS, FOR ORAL USE INITIAL U.S. APPROVAL: 2003 RECENT MAJOR CHANGES Warnings and Precautions ( 5.4) 05/2017 INDICATIONS AND USAGE Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: • erectile dysfunction (ED) ( 1.1) • the signs and symptoms of benign prostatic hyperplasia (BPH) ( 1.2) • ED and the signs and symptoms of BPH (ED/BPH) ( 1.3) If tadalafil tablet is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks ( 1.4). DOSAGE AND ADMINISTRATION • _Tadalafil tablet for use as needed:_ • ED: Starting dose: 10 mg as needed prior to sexual activity. Increase to 20 mg or decrease to 5 mg based upon efficacy/tolerability. Improves erectile function compared to placebo up to 36 hours post dose. Not to be taken more than once per day (2.1). • _Tadalafil tablet for once daily use:_ • ED: 2.5 mg taken once daily, without regard to timing of sexual activity. May increase to 5 mg based upon efficacy and tolerability ( 2.2). • BPH: 5 mg, taken at approximately the same time every day ( 2.3) • ED and BPH: 5 mg, taken at approximately the same time every day ( 2.3, 2.4) • Tadalafil tablets may be taken without regard to food ( 2.5). DOSAGE FORMS AND STRENGTHS Tablets: 2.5 mg, 5 mg, 10 mg, 20 mg ( 3). CONTRAINDICATIONS • Administration of tadalafil tablets to patients using any form of organic nitrate is contraindicated. Tadalafil tablets was shown to potentiate the hypotensive effect of nitrates ( 4.1). • History of known serious hypersensitivity reaction to tadalafil tablets or ADCIRCA ( 4.2). • Administration with guanylate cyclase (GC) stimulators, such as riociguat ( 4.3). WARNINGS AND PRECAUTIONS • Patients should not use tadalafil i Read the complete document